Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Oze

Showing results (121-130 of 240) with videos related to

Pageof 24
Sort By:
Cancers|December 17, 2024
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung CancerMasataka Taoka, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Epidemiology|April 11, 2024
Active and passive smoking and breast cancer in Japan: a pooled analysis of nine population-based cohort studiesKeiko Wada, Chisato Nagata, Mai Utada, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2023
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutationsTakashi Ninomiya, Nobuhisa Ishikawa, Toshiyuki Kozuki, et al.
Acta Oncologica (Stockholm, Sweden)|January 31, 2012
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402Naoyuki Nogami, Katsuyuki Hotta, Yoshihiko Segawa, et al.
International Journal of Cancer|February 16, 2018
Coffee drinking and colorectal cancer and its subsites: A pooled analysis of 8 cohort studies in JapanIkuko Kashino, Shamima Akter, Tetsuya Mizoue, et al.
International Journal of Clinical Oncology|February 16, 2023
Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancerTakahito Kondo, Kiyoaki Tsukahara, Daisuke Kawakita, et al.
Environmental Health and Preventive Medicine|March 3, 2021
Reproducibility and validity of food group intake in a short food frequency questionnaire for the middle-aged Japanese populationNahomi Imaeda, Chiho Goto, Tae Sasakabe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2021
Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority TrialYasuhisa Hasegawa, Kiyoaki Tsukahara, Seiichi Yoshimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2015
Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001Eiki Ichihara, Katsuyuki Hotta, Naoyuki Nogami, et al.
Journal of Epidemiology|December 12, 2017
Body-Mass Index and Pancreatic Cancer Incidence: A Pooled Analysis of Nine Population-Based Cohort Studies With More Than 340,000 Japanese SubjectsYuriko N Koyanagi, Keitaro Matsuo, Hidemi Ito, et al.
Pageof 24

Showing results (121-130 of 240) with videos related to

Sort By:
Pageof 24
Cancers|December 17, 2024
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung CancerMasataka Taoka, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Epidemiology|April 11, 2024
Active and passive smoking and breast cancer in Japan: a pooled analysis of nine population-based cohort studiesKeiko Wada, Chisato Nagata, Mai Utada, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2023
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutationsTakashi Ninomiya, Nobuhisa Ishikawa, Toshiyuki Kozuki, et al.
Acta Oncologica (Stockholm, Sweden)|January 31, 2012
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402Naoyuki Nogami, Katsuyuki Hotta, Yoshihiko Segawa, et al.
International Journal of Cancer|February 16, 2018
Coffee drinking and colorectal cancer and its subsites: A pooled analysis of 8 cohort studies in JapanIkuko Kashino, Shamima Akter, Tetsuya Mizoue, et al.
International Journal of Clinical Oncology|February 16, 2023
Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancerTakahito Kondo, Kiyoaki Tsukahara, Daisuke Kawakita, et al.
Environmental Health and Preventive Medicine|March 3, 2021
Reproducibility and validity of food group intake in a short food frequency questionnaire for the middle-aged Japanese populationNahomi Imaeda, Chiho Goto, Tae Sasakabe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2021
Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority TrialYasuhisa Hasegawa, Kiyoaki Tsukahara, Seiichi Yoshimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2015
Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001Eiki Ichihara, Katsuyuki Hotta, Naoyuki Nogami, et al.
Journal of Epidemiology|December 12, 2017
Body-Mass Index and Pancreatic Cancer Incidence: A Pooled Analysis of Nine Population-Based Cohort Studies With More Than 340,000 Japanese SubjectsYuriko N Koyanagi, Keitaro Matsuo, Hidemi Ito, et al.
Pageof 24